Comparing the effect of intraveous versus perineural magnesium sulphate as adjuvant in supraclavicular block
Phase 4
- Conditions
- Health Condition 1: O- Medical and SurgicalHealth Condition 2: M844- Pathological fracture, not elsewhere classified
- Registration Number
- CTRI/2023/11/060211
- Lead Sponsor
- Rajarajeswari medical college and hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Both sexes, aged between 18-60 years belonging to ASA I and II those who are posted for elective upper limb surgeries (Surgeries of distal humerus, elbow, forearm and hand)
Exclusion Criteria
1. Patient refusal,
2. Pregnant and lactating mothers,
3. ASA III and IV,
4. Known Allergy/contraindication to local anesthetic,
5. Patients having peripheral neuropathy and preexisting neurological defects in upper limbs,
6. Known cases of seizure disorder,
7. Patients with coagulopathies and patients on chronic anticoagulation therapy,
8.Patients with psychiatric illness and local skin infections.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To evaluate and compare the duration of analgesia by intravenous versus perineural MgSO4.Timepoint: VAS score in first 24 hours post surgery.
- Secondary Outcome Measures
Name Time Method To assess the onset and duration of sensory and motor blockade. <br/ ><br>To study analgesic consumption in 24 hours and any side effects. <br/ ><br>Timepoint: Intraoperative and postoperative period 24 hrs post surgery